Publication | Open Access
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
241
Citations
30
References
2018
Year
ClinicalTrials.gov Identifier: NCT01812746.
| Year | Citations | |
|---|---|---|
Page 1
Page 1